Evidence map›Paper›PMID 29616296›Full record

ReviewWorld journal of urology2019

PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach.

Emma Clarebrough, Catriona Duncan, Daniel Christidis, Alain Lavoipierre, Nathan Lawrentschuk

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Novel PET imaging methods for prostate cancer.World journal of urology · 2021
    Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Emma ClarebroughDepartment of Surgery, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia.
Catriona DuncanYoung Urology Research Organisation (YURO), Melbourne, Australia. catriona.m.duncan@gmail.com.ORCID http://orcid.org/0000-0002-6321-4618
Daniel ChristidisYoung Urology Research Organisation (YURO), Melbourne, Australia.
Alain LavoipierreEpworth Medical Imagig, Epworth Freemasons Hospital Melbourne, Melbourne, VIC, Australia.
Nathan LawrentschukDepartment of Urology, Austin Health, Heidelberg, Melbourne, VIC, Australia.
Austin Health · AUAustralian Nuclear Science and Technology Organisation · AUEpworth Hospital · AUThe Royal Melbourne Hospital · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (PSMA-PET/CT) has increased the sensitivity and specificity of imaging to identify metastatic prostate cancer in the group of patients with early biochemical recurrence when compared to conventional imaging. In patients who develop biochemical recurrence of prostate cancer following surgical resection, salvage lymph node dissection may reduce prostate specific antigen (PSA) levels and delay the time for commencement of systemic therapies. However, PLND may be an anatomically and technically difficult procedure, particularly with small metastatic diseases which can be problematic for intra-operative identification. We describe the technique using PSMA-PET imaging to pre-operatively localise areas of low-volume nodal metastatic disease with hookwire to allow targeted lymph node dissection with direct visualisation and palpation to ensure adequate clearance of involved nodes.

Indexed as

Gallium IsotopesGallium RadioisotopesHumansLymphatic MetastasisLymph Node ExcisionLymph NodesMaleMembrane GlycoproteinsOrganometallic CompoundsPelvisPositron-Emission TomographyPositron Emission Tomography Computed TomographyProstatectomyProstate-Specific AntigenProstatic NeoplasmsRadiopharmaceuticalsgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesMembrane GlycoproteinsOrganometallic CompoundsProstate-Specific AntigenRadiopharmaceuticalsHookwireImage guided surgeryLymph node metastasisPelvic lymph node dissectionPET-PSMA scanProstate cancer

Identifiers

PMID29616296
OpenAlexW2795674802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.